{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:45:49Z","timestamp":1793241949950,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T00:00:00Z","timestamp":1421280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s12602-014-9183-1","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T09:48:28Z","timestamp":1421228908000},"page":"164-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), \u03b5-Poly-l-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis"],"prefix":"10.1007","volume":"7","author":[{"given":"Veronica L.","family":"Cavera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Volski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Chikindas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,15]]},"reference":[{"issue":"97","key":"9183_CR1","first-page":"e1","volume":"198","author":"A Swidsinski","year":"2008","unstructured":"Swidsinski A, Mendling W, Loening-Baucke V, Swidsinski S, D\u00f6rffel Y, Scholze J, Lochs H, Verstraelen H (2008) An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol 198(97):e1\u2013e6. doi: 10.1016\/j.ajog.2007.06.039","journal-title":"Am J Obstet Gynecol"},{"key":"9183_CR2","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1128\/JCM.01272-07","volume":"45","author":"DN Fredricks","year":"2007","unstructured":"Fredricks DN, Fiedler TL, Thomas KK, Oakley BB, Marrazzo JM (2007) Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol 45:3270\u20133276. doi: 10.1128\/JCM.01272-07","journal-title":"J Clin Microbiol"},{"key":"9183_CR3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/CMR.5.3.213","volume":"5","author":"BW Catlin","year":"1992","unstructured":"Catlin BW (1992) Gardnerella vaginalis: characteristics, clinical considerations, and controversies. Clin Microbiol Rev 5:213\u2013237","journal-title":"Clin Microbiol Rev"},{"key":"9183_CR4","doi-asserted-by":"crossref","first-page":"284762","DOI":"10.1155\/2012\/284762","volume":"2012","author":"Y Turovskiy","year":"2012","unstructured":"Turovskiy Y, Cheryian T, Algburi A, Wirawan RE, Takhistov P, Sinko PJ, Chikindas ML (2012) Susceptibility of Gardnerella vaginalis biofilms to natural antimicrobials subtilosin, \u03b5-poly-l-lysine, and lauramide arginine ethyl ester. Infect Dis Obstet Gynecol 2012:284762. doi: 10.1155\/2012\/284762","journal-title":"Infect Dis Obstet Gynecol"},{"key":"9183_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2008-2231-21-29","volume":"21","author":"M Barazandeh Tehrani","year":"2013","unstructured":"Barazandeh Tehrani M, Namadchian M, Fadaye Vatan S, Souri E (2013) Derivative spectrophotometric method for simultaneous determination of clindamycin phosphate and tretinoin in pharmaceutical dosage forms. Daru 21:29. doi: 10.1186\/2008-2231-21-29","journal-title":"Daru"},{"key":"9183_CR6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003088-199936050-00004","volume":"36","author":"KC Lamp","year":"1999","unstructured":"Lamp KC, Freeman CD, Klutman NE, Lacy MK (1999) Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin Pharmacokinet 36:353\u2013373. doi: 10.2165\/00003088-199936050-00004","journal-title":"Clin Pharmacokinet"},{"key":"9183_CR7","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1371\/journal.pbio.0050211","volume":"5","author":"D Leitsch","year":"2007","unstructured":"Leitsch D, Kolarich D, Wilson IBH, Altmann F, Duch\u00eane M (2007) Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase. PLoS Biol 5:e211. doi: 10.1371\/journal.pbio.0050211","journal-title":"PLoS Biol"},{"key":"9183_CR8","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/jac\/dkr192","volume":"66","author":"D Leitsch","year":"2011","unstructured":"Leitsch D, Burgess AG, Dunn LA, Krauer KG, Tan K, Duch\u00eane M, Upcroft P, Eckmann L, Upcroft JA (2011) Pyruvate: ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia. J Antimicrob Chemother 66:1756\u20131765. doi: 10.1093\/jac\/dkr192","journal-title":"J Antimicrob Chemother"},{"key":"9183_CR9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1067\/mob.2001.115867","volume":"185","author":"A Aroutcheva","year":"2001","unstructured":"Aroutcheva A, Gariti D, Simon M, Shott S, Faro J, Simoes JA, Gurguis A, Faro S (2001) Defense factors of vaginal lactobacilli. Am J Obstet Gynecol 185:375\u2013379. doi: 10.1067\/mob.2001.115867","journal-title":"Am J Obstet Gynecol"},{"key":"9183_CR10","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1021\/bi0359527","volume":"43","author":"KE Kawulka","year":"2004","unstructured":"Kawulka KE, Sprules T, Diaper CM, Whittal RM, Mckay RT, Mercier P, Zuber P, Vederas JC (2004) Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links : formation and reduction of alpha-thio-alpha-amino acid derivatives. Biochemistry 43:3385\u20133395. doi: 10.1021\/bi0359527","journal-title":"Biochemistry"},{"key":"9183_CR11","doi-asserted-by":"crossref","unstructured":"Drider D, Rebuffat S (2011) Prokaryotic antimicrobial peptides: from genes to applications. Springer, New York. ISBN 978-1-4419-7691-8","DOI":"10.1007\/978-1-4419-7692-5"},{"key":"9183_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12602-010-9061-4","volume":"3","author":"KS Noll","year":"2011","unstructured":"Noll KS, Sinko PJ, Chikindas ML (2011) Elucidation of the molecular mechanisms of action of the natural antimicrobial peptide subtilosin against the bacterial vaginosis-associated pathogen Gardnerella vaginalis. Probiotics Antimicrob Proteins 3:41\u201347. doi: 10.1007\/s12602-010-9061-4","journal-title":"Probiotics Antimicrob Proteins"},{"key":"9183_CR13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.resmic.2012.05.009","volume":"163","author":"Q Liu","year":"2012","unstructured":"Liu Q, Gao G, Xu H, Qiao M (2012) Identification of the bacteriocin subtilosin A and loss of purL results in its high-level production in Bacillus amyloliquefaciens. Res Microbiol 163:470\u2013478. doi: 10.1016\/j.resmic.2012.05.009","journal-title":"Res Microbiol"},{"key":"9183_CR14","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/AAC.05861-11","volume":"56","author":"KS Noll","year":"2012","unstructured":"Noll KS, Prichard MN, Khaykin A, Sinko PJ, Chikindas ML (2012) The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and \u03b5-poly-l-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli. Antimicrob Agents Chemother 56:1756\u20131761. doi: 10.1128\/AAC.05861-11","journal-title":"Antimicrob Agents Chemother"},{"key":"9183_CR15","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.02446-14","volume":"58","author":"S Sundara Rajan","year":"2014","unstructured":"Sundara Rajan S, Cavera VL, Zhang X, Singh Y, Chikindas ML, Sinko PJ (2014) Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis. Antimicrob Agents Chemother 58:2747\u20132753. doi: 10.1128\/AAC.02446-14","journal-title":"Antimicrob Agents Chemother"},{"key":"9183_CR16","unstructured":"Kawamura Y, Whitehouse B (2008) Ethyl lauroyl arginate Chemical and Technical Assessment 1:1\u20135. www.fao.org\/fileadmin\/templates\/agns\/pdf\/jecfa\/cta\/69\/Ethyl_Lauroyl_arginate.pdf . Accessed on November 15, 2014"},{"key":"9183_CR17","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.fct.2009.07.028","volume":"47","author":"DR Hawkins","year":"2009","unstructured":"Hawkins DR, Rocabayera X, Ruckman S, Segret R, Shaw D (2009) Metabolism and pharmacokinetics of ethyl N(alpha)-lauroyl-l-arginate hydrochloride in human volunteers. Food Chem Toxicol 47:2711\u20132715. doi: 10.1016\/j.fct.2009.07.028","journal-title":"Food Chem Toxicol"},{"key":"9183_CR18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1365-2672.2004.02207.x","volume":"96","author":"E Rodr\u00edguez","year":"2004","unstructured":"Rodr\u00edguez E, Seguer J, Rocabayera X, Manresa A (2004) Cellular effects of monohydrochloride of l-arginine, N-lauroyl ethylester (LAE) on exposure to Salmonella typhimurium and Staphylococcus aureus. J Appl Microbiol 96:903\u2013912. doi: 10.1111\/j.1365-2672.2004.02207.x","journal-title":"J Appl Microbiol"},{"key":"9183_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00253-003-1312-9","volume":"62","author":"T Yoshida","year":"2003","unstructured":"Yoshida T, Nagasawa T (2003) Epsilon-poly-l-lysine: microbial production, biodegradation and application potential. Appl Microbiol Biotechnol 62:21\u201326. doi: 10.1007\/s00253-003-1312-9","journal-title":"Appl Microbiol Biotechnol"},{"key":"9183_CR20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1471-2180-13-212","volume":"13","author":"LA Draper","year":"2013","unstructured":"Draper LA, Cotter PD, Hill C, Ross RP (2013) The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria. BMC Microbiol 13:212. doi: 10.1186\/1471-2180-13-212","journal-title":"BMC Microbiol"},{"key":"9183_CR21","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1365-2672.2011.05153.x","volume":"111","author":"A Dobson","year":"2011","unstructured":"Dobson A, O\u2019Connor PM, Cotter PD, Ross RP, Hill C (2011) Impact of the broad-spectrum antimicrobial peptide, lacticin 3147, on Streptococcus mutans growing in a biofilm and in human saliva. J Appl Microbiol 111:1515\u20131523. doi: 10.1111\/j.1365-2672.2011.05153.x","journal-title":"J Appl Microbiol"},{"key":"9183_CR22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12602-009-9033-8","volume":"2","author":"K Naghmouchi","year":"2010","unstructured":"Naghmouchi K, Drider D, Baah J, Teather R (2010) Nisin A and polymyxin B as synergistic inhibitors of Gram positive and Gram negative bacteria. Probiotics Antimicrob Proteins 2:98\u2013103. doi: 10.1007\/s12602-009-9033-8","journal-title":"Probiotics Antimicrob Proteins"},{"key":"9183_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.resmic.2011.11.002","volume":"163","author":"K Naghmouchi","year":"2012","unstructured":"Naghmouchi K, Le Lay C, Baah J, Drider D (2012) Antibiotic and antimicrobial peptide combinations: synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants. Res Microbiol 163:101\u2013108. doi: 10.1016\/j.resmic.2011.11.002","journal-title":"Res Microbiol"},{"key":"9183_CR24","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/AAC.02328-12","volume":"57","author":"K Naghmouchi","year":"2013","unstructured":"Naghmouchi K, Baah J, Hober D, Jouy E, Rubrecht C, San\u00e9 F, Drider D (2013) Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. Antimicrob Agents Chemother 57:2719\u20132725. doi: 10.1128\/AAC.02328-12","journal-title":"Antimicrob Agents Chemother"},{"key":"9183_CR25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10096-008-0617-0","volume":"28","author":"E Biagi","year":"2009","unstructured":"Biagi E, Vitali B, Pugliese C, Candela M, Donders GG, Brigidi P (2009) Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study. Eur J Clin Microbiol Infect Dis 28:281\u2013285. doi: 10.1007\/s10096-008-0617-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9183_CR26","doi-asserted-by":"crossref","first-page":"e45281","DOI":"10.1371\/journal.pone.0045281","volume":"7","author":"GLDS Santiago","year":"2012","unstructured":"Santiago GLDS, Tency I, Verstraelen H, Verhelst R, Trog M, Temmerman M, Vancoillie L, Decat E, Cools P, Vaneechoutte M (2012) Longitudinal qPCR study of the dynamics of L. crispatus, L. iners, A. vaginae, (sialidase positive) G. vaginalis, and P. bivia in the vagina. PLoS One 7:e45281. doi: 10.1371\/journal.pone.0045281","journal-title":"PLoS One"},{"key":"9183_CR27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12602-010-9042-7","volume":"2","author":"T Amrouche","year":"2010","unstructured":"Amrouche T, Sutyak Noll K, Wang Y, Huang Q, Chikindas ML (2010) Antibacterial activity of subtilosin alone and combined with curcumin, poly-l-lysine and zinc lactate against Listeria monocytogenes strains. Probiotics Antimicrob Proteins 2:250\u2013257. doi: 10.1007\/s12602-010-9042-7","journal-title":"Probiotics Antimicrob Proteins"},{"key":"9183_CR28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1472-765X.2007.02157.x","volume":"45","author":"M Badaoui Najjar","year":"2007","unstructured":"Badaoui Najjar M, Kashtanov D, Chikindas ML (2007) \u03b5-poly-l-lysine and nisin A act synergistically against Gram-positive food-borne pathogens Bacillus cereus and Listeria monocytogenes. Lett Appl Microbiol 45:13\u201318. doi: 10.1111\/j.1472-765X.2007.02157.x","journal-title":"Lett Appl Microbiol"},{"key":"9183_CR29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/AAC.01070-07","volume":"52","author":"S Sun","year":"2008","unstructured":"Sun S, Li Y, Guo Q, Shi C, Yu J, Ma L (2008) In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods. Antimicrob Agents Chemother 52:409\u2013417. doi: 10.1128\/AAC.01070-07","journal-title":"Antimicrob Agents Chemother"},{"key":"9183_CR30","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1128\/AAC.48.11.4315-4321.2004","volume":"48","author":"VH Tam","year":"2004","unstructured":"Tam VH, Schilling AN, Lewis RE, Melnick DA, Boucher AN (2004) Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents. Antimicrob Agents Chemother 48:4315\u20134321. doi: 10.1128\/AAC.48.11.4315-4321.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"9183_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1. doi: 10.1093\/jac\/dkg301","journal-title":"J Antimicrob Chemother"},{"key":"9183_CR32","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/AAC.00329-09","volume":"53","author":"V Petraitis","year":"2009","unstructured":"Petraitis V, Petraitiene R, Hope WW, Meletiadis J, Mickiene D, Hughes JE, Cotton MP, Stergiopoulou T, Kasai M, Francesconi A, Schaufele RL, Sein T, Avila NA, Bacher J, Walsh TJ (2009) Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose-dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Antimicrob Agents Chemother 53:2382\u20132391. doi: 10.1128\/AAC.00329-09","journal-title":"Antimicrob Agents Chemother"},{"key":"9183_CR33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/ac00002a010","volume":"63","author":"DB Rorabacher","year":"1991","unstructured":"Rorabacher DB (1991) Statistical treatment for rejection of deviant values: critical values of Dixon\u2019s \u201cQ\u201d parameter and related subrange ratios at the 95% confidence level. Anal Chem 63:139\u2013146. doi: 10.1021\/ac00002a010","journal-title":"Anal Chem"},{"key":"9183_CR34","doi-asserted-by":"crossref","first-page":"706540","DOI":"10.1155\/2012\/706540","volume":"2012","author":"C Mitchell","year":"2012","unstructured":"Mitchell C, Manhart LE, Thomas K, Fiedler T, Fredricks DN, Marrazzo J (2012) Behavioral predictors of colonization with Lactobacillus crispatus or Lactobacillus jensenii after treatment for bacterial vaginosis: a cohort study. Infect Dis Obstet Gynecol 2012:706540. doi: 10.1155\/2012\/706540","journal-title":"Infect Dis Obstet Gynecol"},{"key":"9183_CR35","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/infdis\/174.5.1058","volume":"174","author":"SE Hawes","year":"1996","unstructured":"Hawes SE, Hillier SL, Benedetti J, Stevens CE, Koutsky LA, Wolner-Hanssen P, Holmes KK (1996) Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 174:1058\u20131063","journal-title":"J Infect Dis"},{"key":"9183_CR36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/cid\/cis1030","volume":"56","author":"CS Bradshaw","year":"2013","unstructured":"Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta M, Garland SM, De Guingand D, Morton AN, Fairley CK (2013) Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin Infect Dis 56:777\u2013786. doi: 10.1093\/cid\/cis1030","journal-title":"Clin Infect Dis"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-014-9183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12602-014-9183-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-014-9183-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T08:55:10Z","timestamp":1559465710000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12602-014-9183-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,15]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["9183"],"URL":"https:\/\/doi.org\/10.1007\/s12602-014-9183-1","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,15]]}}}